近亲结婚中国家庭中早发性卵巢功能不全患者的新型AARS2纯合突变
对来自近亲结婚家庭的早发性卵巢功能不全先证者行全外显子组测序,发现AARS2新型纯合突变(NM_020745: exon2: c.337G>C: p.G113R),该突变在物种间高度保守并预测致病;突变组ATP产量(3.58 ± 0.46 fmol/min/cell)显著低于野生型组(6.96 ± 1.56 fmol/min/cell)。
要点
- 在近亲结婚家庭的早发性卵巢功能不全先证者中鉴定出AARS2新型纯合突变c.337G>C(p.G113R)。
- 该突变位于氨酰化区域,在物种间高度保守,预测为致病性突变。
- 突变组ATP产量为3.58 ± 0.46 fmol/min/cell,显著低于野生型组的6.96 ± 1.56 fmol/min/cell。
核心结论
- 本文首次报道早发性卵巢功能不全中的AARS2纯合致病突变。
- 该突变可能导致tRNA氨酰化不正确,影响线粒体翻译并引起氧化磷酸化缺陷,从而可能导致早发性卵巢功能不全。
研究设计与样本
- 遗传学与功能研究,研究对象为来自近亲结婚家庭的早发性卵巢功能不全患者及其家庭成员,招募自安徽医科大学第一附属医院生殖中心。
- 对先证者行全外显子组测序,在家系中用Sanger测序验证变异,并结合公共数据库中其他散发病例的测序数据识别致病基因。
- 使用Seahorse XFe96分析仪进行代谢分析,测量氧消耗并进一步获得ATP产量和细胞外酸化率,比较野生型与突变型之间的能量代谢差异。
主要发现
- 全外显子组测序在氨酰化区域鉴定出新型AARS2纯合突变(NM_020745: exon2: c.337G>C: p.G113R)。
- 该突变在物种间高度保守,预测为致病性突变。
- AARS2编码线粒体丙氨酰-tRNA合成酶,负责将丙氨酸连接到tRNA-ala上。
- AARS2突变既往曾在伴有早发性卵巢功能不全的女性脑白质营养不良患者中报道。
- 线粒体压力测试中,突变组ATP产量(3.58 ± 0.46 fmol/min/cell)显著低于野生型组(6.96 ± 1.56 fmol/min/cell)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To explore the candidate pathogenic gene in a premature ovarian insufficiency (POI) proband from a consanguineous marriage and detect the potential effects of mutation on cellular energy metabolism. DESIGN: Genetic and functional studies. SETTING: Reproductive medicine center. PATIENT(S): A patient with POI, from a consanguineous family, and her family members were recruited from the Reproductive Center of the First Affiliated Hospital of Anhui Medical University. INTERVENTION(S): Whole exome sequencing (WES) was performed for the proband. Variation revealed by WES sequencing was validated by Sanger sequencing in her family. Sequencing data were combined with those of other sporadic cases listed in public databases to identify the causative gene. MAIN OUTCOME MEASURE(S): Rare homozygous nonsynonymous variants were identified and included in subsequent analysis. Metabolic analyzes were performed using Seahorse XFe96 analyzers to measure oxygen consumption and then obtain further results of ATP production and extracellular acidification rate. The differences in energy metabolism measurements between wild type and mutation were analyzed and compared. RESULT(S): A novel alanyl-tRNA synthetase 2 (AARS2) homozygous mutation (NM_020745: exon2: c.337G>C: p. G113R) was identified in the aminoacylation region using WES. The mutation was highly conserved among species and predicted to be disease causing. AARS2 encodes mitochondrial alanyl-tRNA synthetase, which attaches alanine onto tRNA-ala. AARS2 mutations were previously reported in female leukodystrophy patients with POI. In mitochondrial stress tests, the ATP productions of the mutation group (3.58 ± 0.46 fmol/min/cell) was significantly lower than that of the wild type group (6.96 ± 1.56 fmol/min/cell). CONCLUSION(S): This is the first report of a homozygous pathogenic AARS2 mutation in POI. This mutation may lead to incorrect aminoacylation of tRNA, affect mitochondrial translation, and cause oxidative phosphorylation defects, which may be responsible for POI.
引用
- Zhou Y, Chen B, Li L, et al. Novel alanyl-tRNA synthetase 2 (AARS2) homozygous mutation in a consanguineous Chinese family with premature ovarian insufficiency. Fertil Steril. 2019. PMID: 31280959. doi:10.1016/j.fertnstert.2019.05.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。